Johnson & Johnson (JNJ) Financials: History & Chart

Johnson & Johnson (JNJ)JNJJohnson & Johnson

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

New Brunswick, NJ

141,700 employees

www.jnj.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Joaquin Duato

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	97.93B	25.31B	24.06B	24.56B	23.99B	23.74B	21.89B	22.52B	22.47B
Cost of Goods Sold	28.94B	6.81B	6.86B	7.97B	7.30B	7.63B	7.36B	7.13B	6.96B
Gross Profit	68.99B	18.50B	17.20B	16.60B	16.69B	16.11B	14.54B	15.39B	15.51B
Gross Profit Margin	70.5%	73.1%	71.5%	67.6%	69.6%	67.9%	66.4%	68.3%	69.0%
Total Operating Expenses	42.74B	11.33B	10.81B	11.01B	9.59B	9.30B	8.24B	11.55B	10.23B
Research & Development	15.10B	3.65B	3.53B	4.25B	3.67B	3.52B	3.23B	5.30B	4.95B
Selling, General & Administrative	25.14B	6.43B	6.03B	6.75B	5.92B	5.79B	5.01B	6.25B	5.28B
Operating Income (EBIT)	26.26B	7.17B	6.39B	5.59B	7.10B	6.81B	6.30B	3.84B	5.28B
Operating Margin	26.8%	28.3%	26.6%	22.8%	29.6%	28.7%	28.8%	17.1%	23.5%
Income Before Tax (EBT)	25.20B	6.75B	5.99B	4.97B	7.49B	6.49B	13.63B	3.89B	3.34B
Interest Income	693.00M	N/A	229.00M	237.00M	227.00M	260.00M	332.00M	281.00M	292.00M
Interest Expense	793.00M	62.00M	272.00M	214.00M	245.00M	308.00M	204.00M	137.00M	193.00M
Other Income/Expense	-1.06B	-427.00M	-405.00M	-625.00M	397.00M	-319.00M	7.33B	46.00M	-1.94B
Net Income	21.04B	5.53B	5.24B	5.12B	5.15B	5.54B	11.00B	3.43B	2.69B
Income Tax Expense	4.16B	1.21B	755.00M	-150.00M	2.34B	954.00M	2.63B	456.00M	644.00M
Net Profit Margin	21.5%	21.9%	21.8%	20.8%	21.5%	23.3%	50.2%	15.2%	12.0%
EBITDA	32.05B	7.17B	8.40B	7.60B	8.87B	8.75B	8.07B	5.74B	7.12B
EBITDA Margin	32.7%	28.3%	34.9%	30.9%	37.0%	36.9%	36.9%	25.5%	31.7%
Depreciation & Amortization	5.79B	0.00	2.00B	2.01B	1.78B	1.94B	1.77B	1.90B	1.85B
EPS Basic	8.65	2.27	2.14	2.10	2.14	2.29	4.57	1.43	1.12
EPS Diluted	8.63	2.27	2.14	2.10	2.12	2.29	4.54	1.41	1.11
Shares Outstanding	2.44B	2.44B	2.45B	2.43B	2.43B	2.42B	2.41B	2.41B	2.41B
Diluted Shares Outstanding	2.44B	2.44B	2.45B	2.44B	2.43B	2.42B	2.42B	2.43B	2.43B

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/28/2025	12/29/2024	12/31/2023	01/01/2023	01/02/2022	01/03/2021	12/31/2019	12/31/2018
Revenue	94.19B	88.82B	85.16B	79.99B	78.74B	82.58B	82.06B	81.58B
Cost of Goods Sold	25.64B	27.47B	26.55B	24.60B	23.40B	28.43B	27.56B	27.09B
Gross Profit	68.56B	61.35B	58.61B	55.39B	55.34B	54.16B	54.50B	54.49B
Gross Profit Margin	72.8%	69.1%	68.8%	69.3%	70.3%	65.6%	66.4%	66.8%
Total Operating Expenses	42.96B	39.20B	35.20B	34.38B	34.40B	34.42B	33.53B	33.31B
Research & Development	14.66B	17.23B	15.09B	14.13B	14.28B	12.34B	11.36B	10.78B
Selling, General & Administrative	23.68B	21.97B	20.11B	20.25B	20.12B	22.08B	22.18B	22.54B
Operating Income (EBIT)	25.60B	22.15B	23.41B	21.01B	20.94B	19.73B	20.97B	21.18B
Operating Margin	27.2%	24.9%	27.5%	26.3%	26.6%	23.9%	25.6%	26.0%
Income Before Tax (EBT)	32.58B	16.69B	15.06B	19.36B	19.18B	16.50B	17.33B	18.00B
Interest Income	1.06B	1.33B	1.26B	490.00M	53.00M	111.00M	357.00M	611.00M
Interest Expense	971.00M	755.00M	772.00M	276.00M	183.00M	201.00M	318.00M	1.00B
Other Income/Expense	6.99B	-5.46B	-8.35B	-1.65B	-1.76B	-3.24B	-3.64B	-3.18B
Net Income	26.80B	14.07B	35.15B	17.94B	20.88B	14.71B	15.12B	15.30B
Income Tax Expense	5.78B	2.62B	1.74B	2.99B	1.38B	1.78B	2.21B	2.70B
Net Profit Margin	28.5%	15.8%	41.3%	22.4%	26.5%	17.8%	18.4%	18.8%
EBITDA	33.10B	29.49B	30.89B	27.98B	28.33B	26.96B	27.98B	28.10B
EBITDA Margin	35.1%	33.2%	36.3%	35.0%	36.0%	32.7%	34.1%	34.4%
Depreciation & Amortization	7.50B	7.34B	7.49B	6.97B	7.39B	7.23B	7.01B	6.93B
EPS Basic	11.03	5.84	13.88	6.83	7.93	5.59	5.74	5.75
EPS Diluted	11.03	5.79	13.72	6.73	7.81	5.51	5.63	5.61
Shares Outstanding	2.43B	2.41B	2.53B	2.61B	2.63B	2.63B	2.63B	2.66B
Diluted Shares Outstanding	2.43B	2.43B	2.56B	2.66B	2.67B	2.67B	2.68B	2.73B

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.